Inhibikase Therapeutics Inc (IKT)

Total Costs & Expenses

$65.81M

TTM · Period ending: · USD

IKT logo

IKT Total Costs & Expenses

Latest reported$65.81M
IKT TTM Total Costs & Expenses ($4.58M → $65.81M)
High-resolution chart · PNG

IKT total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Inhibikase Therapeutics Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
65,810,267
55,591,550
51,974,283
51,127,357
44,186,460
38,404,717
28,589,071
20,063,938
19,084,907
20,353,183
20,350,293
20,345,266
20,017,211
18,344,891
18,252,048
18,896,913
19,176,022
18,520,936
17,866,745
14,194,603
10,096,493
6,738,594
3,516,960
2,808,236
3,311,453
5,016,559
5,938,424
7,880,034
7,479,694
5,884,569
4,578,575
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.